Literature DB >> 16842126

Myostatin: biology and clinical relevance.

Gilles Carnac1, Stéphanie Ricaud, Barbara Vernus, Anne Bonnieu.   

Abstract

Myostatin is a negative regulator of muscle mass. Important advances in our understanding of the complex biology of this factor have revealed the therapeutic potential of antagonizing the myostatin pathway. Here we present the rationale for evaluating anti-myostatin therapies in human muscle-wasting disorders.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16842126     DOI： 10.2174/138955706777698642

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN： 1389-5575            Impact factor:   3.862


  14 in total

1.  Antisense-induced myostatin exon skipping leads to muscle hypertrophy in mice following octa-guanidine morpholino oligomer treatment.

Authors:  Jagjeet K Kang; Alberto Malerba; Linda Popplewell; Keith Foster; George Dickson
Journal:  Mol Ther       Date:  2010-10-05       Impact factor: 11.454

2.  Foxo/atrogin induction in human and experimental myositis.

Authors:  Han-Kyu Lee; Edward Rocnik; Qinghao Fu; Bumsup Kwon; Ling Zeng; Kenneth Walsh; Henry Querfurth
Journal:  Neurobiol Dis       Date:  2012-05       Impact factor: 5.996

Review 3.  Identification of possible cigarette smoke constituents responsible for muscle catabolism.

Authors:  Oren Rom; Sharon Kaisari; Dror Aizenbud; Abraham Z Reznick
Journal:  J Muscle Res Cell Motil       Date:  2012-05-22       Impact factor: 2.698

4.  Schisandrae Fructus Supplementation Ameliorates Sciatic Neurectomy-Induced Muscle Atrophy in Mice.

Authors:  Joo Wan Kim; Sae-Kwang Ku; Ki Young Kim; Sung Goo Kim; Min Ho Han; Gi-Young Kim; Hye Jin Hwang; Byung Woo Kim; Cheol Min Kim; Yung Hyun Choi
Journal:  Oxid Med Cell Longev       Date:  2015-05-12       Impact factor: 6.543

5.  Gene doping in sport - perspectives and risks.

Authors:  E Brzeziańska; D Domańska; A Jegier
Journal:  Biol Sport       Date:  2014-09-12       Impact factor: 2.806

6.  Inflammatory Mechanisms Associated with Skeletal Muscle Sequelae after Stroke: Role of Physical Exercise.

Authors:  Hélio José Coelho Junior; Bruno Bavaresco Gambassi; Tiego Aparecido Diniz; Isabela Maia da Cruz Fernandes; Érico Chagas Caperuto; Marco Carlos Uchida; Fabio Santos Lira; Bruno Rodrigues
Journal:  Mediators Inflamm       Date:  2016-08-28       Impact factor: 4.711

7.  Dual Myostatin and Dystrophin Exon Skipping by Morpholino Nucleic Acid Oligomers Conjugated to a Cell-penetrating Peptide Is a Promising Therapeutic Strategy for the Treatment of Duchenne Muscular Dystrophy.

Authors:  Alberto Malerba; Jagjeet K Kang; Graham McClorey; Amer F Saleh; Linda Popplewell; Michael J Gait; Matthew Ja Wood; George Dickson
Journal:  Mol Ther Nucleic Acids       Date:  2012-12-18       Impact factor: 10.183

8.  The administration of Fructus Schisandrae attenuates dexamethasone-induced muscle atrophy in mice.

Authors:  Joo Wan Kim; Sae-Kwang Ku; Min Ho Han; Ki Young Kim; Sung Goo Kim; Gi-Young Kim; Hye Jin Hwang; Byung Woo Kim; Cheol Min Kim; Yung Hyun Choi
Journal:  Int J Mol Med       Date:  2015-05-04       Impact factor: 4.101

Review 9.  Ongoing developments in sporadic inclusion body myositis.

Authors:  Pedro M Machado; Mhoriam Ahmed; Stefen Brady; Qiang Gang; Estelle Healy; Jasper M Morrow; Amanda C Wallace; Liz Dewar; Gita Ramdharry; Matthew Parton; Janice L Holton; Henry Houlden; Linda Greensmith; Michael G Hanna
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

10.  Age-dependent alteration in muscle regeneration: the critical role of tissue niche.

Authors:  Laura Barberi; Bianca Maria Scicchitano; Manuela De Rossi; Anne Bigot; Stephanie Duguez; Aurore Wielgosik; Claire Stewart; Jamie McPhee; Maria Conte; Marco Narici; Claudio Franceschi; Vincent Mouly; Gillian Butler-Browne; Antonio Musarò
Journal:  Biogerontology       Date:  2013-05-12       Impact factor: 4.277
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.